Oaktree Acquisition III Life Sciences
OACCU · NASDAQ
About OACCU
- Employees
- 0
- Headquarters
- Los Angeles, California
- Listed
- Dec 16, 2024
- Sector
- N/A
- Industry
- N/A
OACCU key statistics
- Market cap
- 263.28M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 149
- Volume
- 102
- Open price
- $10.75
- High today
- $10.80
- Low today
- $10.80
- 52 Week high
- $12.47
- 52 Week low
- $10.64
Oaktree Acquisition III Life Sciences (OACCU) at a glance
Oaktree Acquisition III Life Sciences (OACCU) last traded at $10.80, with a market cap of 263.28M and a price-to-earnings ratio of 0.00.
Volume so far is 102 shares, below the average of 149 shares a day.
Over the past year Oaktree Acquisition III Life Sciences has ranged from $10.64 to $12.47, and now sits 9% of the way up that range.
OACCU news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.